1. A drug repurposing approach for individualized cancer therapy based on transcriptome sequencing and virtual drug screening. (May 2023) Authors: Kadioglu, Onat; Bahramimehr, Faranak; Dawood, Mona; Mahmoud, Nuha; Elbadawi, Mohamed; Lu, Xiaohua; Bülbül, Yagmur; Schulz, Jana Agnieszka; Krämer, Lisa; Urschel, Marie-Kathrin; Künzli, Zoe; Abdulrahman, Leila; Aboumaachar, Fadwa; Kadalo, Lajien; Nguyen, Le Van; Shaidaei, Sara; Thaher, Nawal; Walt... Journal: Computers in biology and medicine Issue: Volume 157(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial. Issue 6 (June 2022) Authors: Dimopoulos, Meletios A; Richardson, Paul G; Bahlis, Nizar J; Grosicki, Sebastian; Cavo, Michele; Beksaç, Meral; Legieć, Wojciech; Liberati, Anna M; Goldschmidt, Hartmut; Belch, Andrew; Magen, Hila; Larocca, Alessandra; Laubach, Jacob P; Petrucci, Maria T; Reece, Donna; White, Darrell; Mateos, Mar... Journal: Lancet Issue: Volume 9:Issue 6(2022) Page Start: e403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Granulocyte functions are independent of arginine availability. Issue 6 (7th August 2014) Authors: Kapp, Katharina; Prüfer, Steve; Michel, Christian S.; Habermeier, Alice; Luckner‐Minden, Claudia; Giese, Thomas; Bomalaski, John; Langhans, Claus‐Dieter; Kropf, Pascale; Müller, Ingrid; Closs, Ellen I.; Radsak, Markus P.; Munder, Markus Journal: Journal of leukocyte biology Issue: Volume 96:Issue 6(2014) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Granulocyte functions are independent of arginine availability. Issue 6 (7th August 2014) Authors: Kapp, Katharina; Prüfer, Steve; Michel, Christian S; Habermeier, Alice; Luckner-Minden, Claudia; Giese, Thomas; Bomalaski, John; Langhans, Claus-Dieter; Kropf, Pascale; Müller, Ingrid; Closs, Ellen I; Radsak, Markus P; Munder, Markus Journal: Journal of leukocyte biology Issue: Volume 96:Issue 6(2014) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial. (8th February 2021) Authors: Hungria, Vania; Beksac, Meral; Weisel, Katja C.; Nooka, Ajay K.; Masszi, Tamas; Spicka, Ivan; Munder, Markus; Mateos, María‐Victoria; Mark, Tomer M.; Qi, Ming; Qin, Xiang; Fastenau, John; Spencer, Andrew; Sonneveld, Pieter; Garvin, Wendy; Renaud, Thomas; Gries, Katharine S. Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Induced arginine transport via cationic amino acid transporter‐1 is necessary for human T‐cell proliferation. Issue 1 (2nd November 2015) Authors: Werner, Anke; Amann, Eva; Schnitzius, Vanessa; Habermeier, Alice; Luckner‐Minden, Claudia; Leuchtner, Nadine; Rupp, Johanna; Closs, Ellen I.; Munder, Markus Journal: European journal of immunology Issue: Volume 46:Issue 1(2016) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Monoclonal gammopathy of ocular significance (MGOS) – a short survey of corneal manifestations and treatment outcomes. Issue 4 (21st March 2022) Authors: Garderet, Laurent; Al Hariri, Mohammad; Wasielica-Poslednik, Joanna; Munder, Markus; Kormányos, Kitti; Pena, Camila; Gozzetti, Alessandro; Zhou, Xiang; Waszczuk-Gajda, Anna; Rosinol, Laura; Mikala, Gabor; Krzystanski, Mateusz; Lisch, Walter; Vesole, David; Szentmáry, Nóra; Jurczyszyn, Artur Journal: Leukemia & lymphoma Issue: Volume 63:Issue 4(2022) Page Start: 984 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial. Issue 8 (22nd November 2022) Authors: Sonneveld, Pieter; Chanan-Khan, Asher; Weisel, Katja; Nooka, Ajay K.; Masszi, Tamas; Beksac, Meral; Spicka, Ivan; Hungria, Vania; Munder, Markus; Mateos, Maria-Victoria; Mark, Tomer M.; Levin, Mark-David; Ahmadi, Tahamtan; Qin, Xiang; Garvin Mayo, Wendy; Gai, Xue; Carey, Jodi; Carson, Robin; Spen... Journal: Journal of clinical oncology Issue: Volume 41:Issue 8(2023) Page Start: 1600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Role of arginase in asthma: potential clinical applications. Issue 1 (January 2010) Authors: Munder, Markus Journal: Expert review of clinical pharmacology Issue: Volume 3:Issue 1(2010) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma. (3rd October 2018) Authors: Awwad, Mohamed H. S.; Kriegsmann, Katharina; Plaumann, Julian; Benn, Michael; Hillengass, Jens; Raab, Marc S.; Bertsch, Uta; Munder, Markus; Weisel, Katja; Salwender, Hans Jürgen; Hänel, Mathias; Fenk, Roland; Dürig, Jan; Müller-Tidow, Carsten; Goldschmidt, Hartmut; Hundemer, Michael Journal: Oncoimmunology Issue: Volume 7:Number 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗